Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
Key Metrics
as of Sep 2026
Market Cap 15,375 Cr
P/E 82.00
Div Yield 0.13 %
Book Value βΉ93.00
52w High βΉ1,573.00
52w Low βΉ848.00
Face Value βΉ1.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
219.00
207.00
193.00
189.00
177.00
162.00
156.00
170.00
142.00
141.00
129.00
136.00
119.00
Expenses
124.00
115.00
110.00
111.00
107.00
97.00
94.00
100.00
87.00
84.00
78.00
80.00
71.00
Operating Profit
95.00
92.00
83.00
79.00
71.00
65.00
62.00
71.00
56.00
57.00
51.00
56.00
47.00
OPM %
43.00
44.00
43.00
41.00
40.00
40.00
40.00
41.00
39.00
41.00
40.00
41.00
40.00
Other Income
9.00
7.00
6.00
5.00
7.00
4.00
5.00
5.00
4.00
3.00
3.00
7.00
6.00
Depreciation
22.00
21.00
21.00
19.00
18.00
17.00
17.00
15.00
15.00
15.00
14.00
14.00
12.00
Interest
10.00
9.00
8.00
7.00
7.00
7.00
6.00
6.00
6.00
6.00
6.00
6.00
6.00
Profit before tax
71.00
69.00
59.00
57.00
53.00
46.00
44.00
54.00
38.00
40.00
34.00
44.00
35.00
Tax %
25.00
23.00
25.00
25.00
26.00
27.00
24.00
26.00
25.00
23.00
25.00
25.00
26.00
Net Profit
53.00
53.00
44.00
43.00
39.00
33.00
34.00
40.00
29.00
31.00
25.00
33.00
26.00
EPS in Rs
5.17
5.14
4.30
4.16
3.80
3.26
3.27
3.87
2.81
2.98
2.47
3.21
2.55
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Sales
765.00 634.00 525.00 450.00 451.00 367.00 329.00 279.00 238.00
Expenses
443.00 379.00 313.00 271.00 251.00 204.00 196.00 187.00 160.00
Operating Profit
322.00 255.00 212.00 179.00 200.00 163.00 133.00 92.00 78.00
OPM %
42.00 40.00 40.00 40.00 44.00 44.00 40.00 33.00 33.00
Other Income
25.00 17.00 19.00 15.00 13.00 11.00 12.00 9.00 5.00
Interest
31.00 25.00 24.00 21.00 16.00 15.00 15.00 4.00 4.00
Depreciation
80.00 65.00 55.00 61.00 52.00 50.00 48.00 26.00 23.00
Profit before tax
236.00 183.00 152.00 111.00 144.00 110.00 82.00 70.00 56.00
Tax %
25.00 26.00 25.00 25.00 25.00 24.00 25.00 31.00 36.00
Net Profit
178.00 136.00 115.00 83.00 108.00 83.00 61.00 49.00 35.00
EPS in Rs
17.33 13.24 11.20 8.15 10.60 18.28 135.13 108.02 78.17
Dividend Payout %
12.00 15.00 9.00 12.00 9.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Equity Capital
10.00 10.00 10.00 10.00 10.00 5.00 5.00 5.00 5.00
Reserves
933.00 770.00 643.00 535.00 460.00 356.00 273.00 211.00 162.00
Borrowings
396.00 292.00 250.00 248.00 183.00 137.00 156.00 36.00 26.00
Other Liabilities
120.00 149.00 59.00 57.00 58.00 36.00 41.00 40.00 31.00
Total Liabilities
1,460.00 1,221.00 962.00 850.00 711.00 533.00 475.00 292.00 224.00
Fixed Assets
862.00 673.00 582.00 517.00 364.00 261.00 264.00 137.00 102.00
CWIP
35.00 67.00 9.00 28.00 34.00 9.00 10.00 3.00 3.00
Investments
368.00 326.00 254.00 144.00 59.00 32.00 58.00 73.00 77.00
Other Assets
195.00 154.00 117.00 161.00 254.00 231.00 143.00 80.00 42.00
Total Assets
1,460.00 1,221.00 962.00 850.00 711.00 533.00 475.00 292.00 224.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Cash from Operating Activity
256.00 208.00 175.00 163.00 155.00 128.00 109.00 77.00 62.00
Cash from Investing Activity
-166.00 -167.00 -139.00 -108.00 -127.00 -129.00 -34.00 -91.00 -100.00
Cash from Financing Activity
-63.00 -47.00 -43.00 -41.00 -25.00 -48.00 -28.00 8.00 -7.00
Net Cash Flow
27.00 -5.00 -8.00 13.00 4.00 -49.00 46.00 -7.00 -44.00
Free Cash Flow
91.00 137.00 92.00 38.00 35.00 97.00 62.00 18.00 31.00
CFO/OP %
95.00 96.00 98.00 105.00 97.00 97.00 99.00 104.00 105.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Debtor Days
10.00 7.00 9.00 7.00 8.00 7.00 9.00 14.00 14.00
Inventory Days
18.00 18.00 26.00 12.00 22.00 16.00 23.00 19.00 24.00
Days Payable
143.00 141.00 178.00 172.00 108.00 133.00 163.00 175.00 152.00
Cash Conversion Cycle
-114.00 -116.00 -143.00 -153.00 -79.00 -110.00 -130.00 -142.00 -115.00
Working Capital Days
-35.00 -47.00 -28.00 -37.00 -32.00 -21.00 -40.00 -28.00 -22.00
ROCE %
22.00 20.00 19.00 18.00 28.00 27.00 27.00 33.00 β
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
52.51
52.51
52.60
52.60
52.63
53.05
53.91
53.91
53.92
54.06
54.87
54.90
FIIs
11.65
13.38
15.10
18.27
19.56
19.36
17.54
18.14
20.08
20.09
19.95
20.68
DIIs
31.61
29.93
28.60
25.34
24.07
23.72
24.62
23.45
21.49
20.80
19.82
18.64
Public
4.22
4.17
3.70
3.77
3.73
3.86
3.92
4.49
4.50
5.03
5.36
5.78
No. of Shareholders
67,251
62,946
57,784
58,994
62,115
66,891
60,952
62,258
62,415
66,724
66,204
72,795
Corporate Actions
4 records
Back to all stocks